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Abstract. 
 
Speciﬁcity and modulation of integrin func-
tion have important consequences for cellular re-
sponses to the extracellular matrix, including differenti-
ation and transformation. The Ras-related GTPase,
R-Ras, modulates integrin afﬁnity, but little is known of 
the signaling pathways and biological functions down-
stream of R-Ras. Here we show that stable expression 
of activated R-Ras or the closely related TC21 (R-Ras 
2) induced integrin-mediated migration and invasion of 
breast epithelial cells through collagen and disrupted 
differentiation into tubule structures, whereas domi-
nant negative R-Ras had opposite effects. These results 
imply novel roles for R-Ras and TC21 in promoting a 
transformed phenotype and in the basal migration and 
polarization of these cells. Importantly, R-Ras induced 
an increase in cellular adhesion and migration on col-
lagen but not ﬁbronectin, suggesting that R-Ras signals 
to speciﬁc integrins. This was further supported by ex-
periments in which R-Ras enhanced the migration of 
 
cells expressing integrin chimeras containing the 
 
a
 
2
 
, 
but not the 
 
a
 
5,
 
 cytoplasmic domain. In addition, a 
transdominant inhibition previously noted only be-
tween integrin 
 
b
 
 cytoplasmic domains was observed for 
the 
 
a
 
2
 
 cytoplasmic domain; 
 
a
 
2
 
b
 
1
 
-mediated migration 
was inhibited by the expression of excess 
 
a
 
2
 
 but not 
 
a
 
5
 
 
cytoplasmic domain-containing chimeras, suggesting 
the existence of limiting factors that bind the integrin
 
a
 
 subunit. Using pharmacological inhibitors, we found 
that R-Ras induced migration on collagen through a 
combination of phosphatidylinositol 3-kinase and pro-
tein kinase C, but not MAPK, which is distinct from the 
other Ras family members, Rac, Cdc42, and N- and
K-Ras. Thus, R-Ras communicates with speciﬁc inte-
grin 
 
a
 
 cytoplasmic domains through a unique combina-
tion of signaling pathways to promote cell migration 
and invasion.
Key words: integrins • Ras • cell migration • transfor-
mation • signaling
 
I
 
NTEGRINS
 
 are a family of 
 
a
 
/
 
b
 
 heterodimers that medi-
ate cellular interactions with components of the ex-
tracellular matrix, resulting in regulation of cell dif-
ferentiation, growth control, and cellular migration and
invasion. Integrins participate in a number of signaling
events in cells. Signaling events induced by the extracellu-
lar matrix through integrins, termed outside-in signaling,
include activation of the mitogen-activated protein kinase
 
(MAPK)
 
1
 
 pathway, cytoplasmic tyrosine kinases such as
 
focal adhesion kinase, phosphoinositide turnover, Ca
 
2
 
1
 
 in-
flux, Na
 
1
 
/ H
 
1
 
 exchange, and alterations in gene expression
and cellular growth (for review see Clark and Brugge,
1995; Schwartz et al., 1995; Yamada and Miyamoto, 1995;
Burridge and Chrzanowska-Wodnicka, 1996; Howe et al.,
1998). Signaling events also impinge upon integrin func-
tion by regulating the ability of integrins to bind their
ligands, a process termed inside-out signaling or integrin
activation. Regulation of integrin–ligand interactions by
 
inside-out signaling helps determine the nature of cellu-
lar responses to the extracellular matrix, influencing deci-
sions such as whether a cell will remain stationary or mi-
grate (Palecek et al., 1997). Integrin cytoplasmic domains,
though relatively short, are necessary for their participa-
tion in both outside-in and inside-out signaling events. De-
spite much recent progress, the current understanding of
integrin-related signaling events is still in its infancy.
One of the most intriguing, but poorly understood, as-
pects of integrin function is how specific integrin subunits
link to specific signaling pathways to create the appropri-
ate cellular response. A handful of studies have begun to
address this question (Sastry et al., 1996; Wary et al., 1996;
Wei et al., 1998). For example, differences in integrin ef-
fects have been correlated to the ability of certain integrin
subunits (
 
a
 
1
 
b
 
1, 
 
a
 
5
 
b
 
1, and 
 
a
 
v
 
b
 
3) but not others (
 
a
 
2
 
b
 
1,
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1. 
 
Abbreviations used in this paper: 
 
MAPK, mitogen-activated protein ki-
nase; MEK, MAPK kinase; PI3K, phosphatidylinositol 3-kinase; PI4K,
phosphatidylinositol 4-kinase; PKC, protein kinase C. 
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a
 
3
 
b
 
1, and 
 
a
 
6
 
b
 
1) to recruit Shc and activate the MAPK
pathway (Wary et al., 1996). Moreover, integrin subunit
specificity has been shown for association of integrins with
transmembrane-4 superfamily proteins and activation of
phosphatidylinositol 4-(PI4) kinase (Yauch et al., 1998).
Although these studies begin to address specificity of out-
side-in signaling pathways, less well-studied is the specific-
ity of inside-out signaling pathways.
Recently, it has become evident that both outside-in and
inside-out integrin signaling pathways can involve small
GTPases of the Ras superfamily (for review see Howe et al.,
1998; Keely et al., 1998). Integrins signaling collaborates
with growth factor–induced signaling through the Ras-
MAPK pathway (Miyamoto et al., 1996; Lin et al., 1997;
Renshaw et al., 1997), and can directly activate the MAPK
pathway by both Ras-dependent and -independent means
(P. Chen et al., 1994; Schlaepfer et al., 1994; Morino
et al., 1995; Zhu and Assoian, 1995; Chen et al., 1996;
Clark and Hynes, 1996; Miyamoto et al., 1996). Signaling
through integrins also activates signaling pathways involv-
ing members of the Rho family of GTPases (Hotchin and
Hall, 1995; Laudanna et al., 1996; Renshaw et al., 1996;
Schwartz et al., 1996; Udagawa and McIntyre, 1996). The
bidirectional nature of these signaling events is demon-
strated by the finding that integrin clustering into focal
complexes can be regulated by Rho family members, Rho,
Rac, and Cdc42 (Hotchin and Hall, 1995; Nobes and Hall,
1995; Clark et al., 1998) or by Ras (Kinch et al., 1995). Ad-
ditionally, activation of Rac and Cdc42 stimulates integrin-
mediated migration and invasion across collagen matrices
(Keely et al., 1997). Ras family members have direct ef-
fects on integrin function, since H-Ras suppresses integrin
activation (Hughes et al., 1997), whereas R-Ras activates
integrins, resulting in increased cell adhesion and matrix
assembly (Zhang et al., 1996).
R-Ras is a 23-kD GTP-binding molecule 
 
z
 
55% homol-
ogous to H-, N-, and K-Ras, with an extra 26 amino acids
at its NH
 
2
 
 terminus (Lowe et al., 1987). Despite this ho-
mology, the biological function of R-Ras is distinct from
H-Ras (Cox et al., 1994; Rey et al., 1994; Marte et al., 1996;
Huff et al., 1997). R-Ras binds to many of the same effec-
tors as H-, N-, or K-Ras, including Raf and Ral-GDS
(Spaargaren and Bischoff, 1994; Spaargaren et al., 1994),
but is unable to activate these effectors efficiently (Herr-
mann et al., 1996; Marte et al., 1996). However, R-Ras is
able to activate the phosphatidylinositol 3-kinase (PI3K)-
Akt/PKB pathway (Marte et al., 1996). The transforming
properties of R-Ras remain under investigation, and are
partially dependent on the specific cell in question (Lowe
and Goeddel, 1987; Cox et al., 1994; Saez et al., 1994).
TC21 (R-Ras2), the closest relative of R-Ras, is also impli-
cated in cellular transformation of fibroblasts and human
breast carcinomas (Clark et al., 1996; Graham et al., 1996),
although TC21 shares more functional similarity to H-Ras
than R-Ras (Huff et al., 1997). Other than PI3K activa-
tion, the signaling pathways and full range of biological ef-
fects downstream of R-Ras function are not known.
We previously showed that stable expression of consti-
tutively active Cdc42 or Rac alters the response of breast
epithelial cells to a collagen matrix by disrupting polari-
zation and promoting a migratory invasive phenotype
(Keely et al., 1997). The effect of Cdc42 and Rac is medi-
 
ated by PI3K (Keely et al., 1997). Additionally, the ability
of these cells to polarize or migrate in collagenous matri-
ces is related to 
 
a
 
2
 
b
 
1 integrin expression levels (Keely et al.,
1995; Zutter et al., 1995). Since R-Ras has been shown to
have direct effects on both integrin function and PI3K ac-
tivity, we determined in this study whether R-Ras can alter
breast cell response to the extracellular matrix. We find
that R-Ras activation disrupts the polarized differentia-
tion of breast epithelial cells in collagen matrices and stim-
ulates migration and invasion through collagen, suggesting
new roles for R-Ras. Additionally, we find that R-Ras spe-
cifically stimulates migration and adhesion to collagen but
not fibronectin. Using integrin chimeras, we demonstrate
cross-talk between R-Ras and the 
 
a
 
2, but not the 
 
a
 
5, inte-
grin cytoplasmic tail, resulting in enhanced migration of
breast epithelial cells. Surprisingly, R-Ras–induced mi-
gration was only partially dependent on PI3K activity,
suggesting that PI3K-independent signaling pathways
also contribute to the effects of R-Ras. We find that one
of these pathways involves protein kinase C (PKC). Mi-
gration induced by R-Ras did not involve the MAPK ki-
nase (MEK)/MAPK pathway, which differed from K-Ras–
induced migration. Thus, R-Ras affects specific integrin 
 
a
 
cytoplasmic domains through multiple distinct combina-
tions of signaling pathways to activate cell migration and
transformation.
 
Materials and Methods
 
Cell Lines
 
T47D cells (American Type Culture Collection) were transfected with
constitutively active constructs for R-Ras(87L) or (38V), TC21(72L),
N-Ras(12D), or K-Ras(12V), or with dominant negative constructs for
R-Ras(41A) or (43N), or TC21(26A) that were expressed in pZIP. Cells
were selected in G418 as described (Keely et al., 1995) and expanded as
pools of stably transfected cells. Control cells were transfected with pZIP
alone and selected in parallel with the other cells. Expression of constructs
was determined by immunoblotting. Because these different molecules
could not be probed by the same antibody on the same blot, it was impos-
sible to determine absolute expression levels of R-Ras compared with
TC21, N-Ras, or K-Ras. However, a comparison of each molecule to en-
dogenous levels was made: R-Ras(87L) was 8.8-fold above endogenous
R-Ras (or 8.8
 
3
 
), R-Ras(43N) 
 
5
 
 10.7
 
3
 
, R-Ras(41A) 
 
5 
 
1.8
 
3
 
, TC21(72L) 
 
5
 
4.0
 
3
 
, TC21(26A) 
 
5 
 
1.0
 
3
 
, N-Ras(12D) 
 
5 
 
0.9
 
3
 
, and K-Ras(12V) 
 
5 
 
2.1
 
3
 
.
For double transfectants to create X4 chimeric cell lines, cells were
cotransfected with X4 chimeras expressed in pSFneo and pCGN (20:1),
and selected in hygromycin-containing growth medium as described (Keely
et al., 1997). Expression of 
 
a
 
4 integrin on the surface of the cell, indicating
expression of the X4 chimeras, was determined by flow cytometry (see be-
low). X4 chimeras were a gift of Dr. Martin Hemler (Dana-Farber Cancer
Institute).
 
Cell Migration, Invasion, and Morphogenesis
 
Migration and invasion across transwells were performed as described
previously (Santoro et al., 1994; Keely et al., 1995, 1997). Transwells were
coated from the underside with 6 
 
m
 
g/ml collagen I or 25 
 
m
 
g/ml fibronectin
(Collaborative Biomedical Products). For studies with X4 chimeras, trans-
wells were coated with specific 
 
a
 
4 ligands: 6 
 
m
 
g/ml of the 40-kD chymo-
tryptic heparin binding fragment of fibronectin (GIBCO BRL) (McCar-
thy et al., 1986) or 50 
 
m
 
g/ml of the CS-1 peptide (EILDVPST; Peninsula
Labs Inc.) (Humphries et al., 1987). CS-1 peptide was coupled to ovalbu-
min as described (Haugen et al., 1990) and the best coating concentration
for cell migration was determined. Cell migration was performed in the
absence of serum or growth factors for 16 h. For inhibitor assays, cells
were pretreated for 15 min with DMSO (control), Wortmannin (30 nM),
LY294002 (25 
 
m
 
M), bisindolylmalemide (1 
 
m
 
M) all from Calbiochem-
Novabiochem Corp., or PD98059 (25 
 
m
 
M; Alexis Biochemicals), and al- 
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lowed to migrate across collagen in the continued presence of the inhibi-
tor for 5 h. 
For antibody inhibition assays, cells were preincubated with control
IgG or anti–
 
a
 
2 integrin antibody, P1E6 (GIBCO BRL) at a final concen-
tration of 1:1,000. Migration was performed in the continued presence of
the antibody for 16 h. Invasion was assessed on serum starved cells that
were seeded onto the top of 2-mm collagen gels and allowed to migrate in
response to 10% serum placed in the lower chamber. Invasion assays were
allowed to proceed for 26–36 h. Unless otherwise noted, values presented
are the mean 
 
6
 
 SEM of at least three experiments normalized to control
values. Data were analyzed by performing ANOVA using Microsoft Ex-
cel software. Morphogenesis in three-dimensional collagen gels was as-
sessed after 7 and 16 d as described (Santoro et al., 1994; Keely et al.,
1995).
 
Adhesion Assays
 
Adhesion to Immobilon plates (Dynatech) coated with various concentra-
tions of collagen I or fibronectin was performed and adherent cells quanti-
tated by hexosaminidase activity as described (Haugen et al., 1990; Keely
et al., 1995). Values given represent the average of two separate experi-
ments, each of triplicate determinations, 
 
6
 
 SEM.
 
Flow Cytometry
 
Cells were detached in versene, washed in PBS containing 5 mg/ml BSA,
and incubated with primary antibody on ice. To determine cell surface in-
tegrin expression, cells were incubated with the following mAbs: P4C2
against the 
 
a
 
4, P1D5 against the 
 
a
 
5, P1E6 against the 
 
a
 
2, or P1B5 against
the 
 
a
 
3 subunits (all from GIBCO BRL), or TS2-7 against the 
 
a
 
1, or 4F10
against the 
 
a
 
6 subunits (Serotec). Primary antibody was diluted 1:1000.
After a 20-min incubation, cells were washed once in PBS/BSA, and incu-
bated with FITC-conjugated donkey anti–mouse secondary antibody at
1:100 (Jackson Labs) for 20 min on ice. Cells were washed again and ana-
lyzed on a Beckman FACScan
 
®
 
. For conformation studies, cells were ei-
ther treated with EDTA or with manganese at 2 mM before incubation
with 12G10 antibody (Serotec), which detects conformational changes in
the 
 
b
 
1 integrin subunit. After this primary antibody incubation, analysis
proceeded as above.
 
PKC Kinase Assay
 
Cells were pretreated with DMSO or bisindolylmaleimide (1 
 
m
 
M) for 20
min, lysed in buffer containing 0.05% Triton-X 100, and the in vitro activ-
ity of PKC was determined on crude lysates using the PKC assay system
(SignaTECT; Promega Corp.), according to manufacturer’s directions. In
brief, a single purification step over a DEAE cellulose column was used to
generate a crude PKC-containing fraction. Background activity (nonspe-
cific) was determined in the absence of phosphatidylserine and diacylglyc-
erol, and compared with PKC activity determined in the presence of phos-
phatidylserine and diacylglycerol.
 
MAPK Activity
 
Cells expressing R-Ras(87L), R-Ras(38V), TC21(72L), K-Ras(12V),
N-Ras(12D), or control vectors were cultured overnight either in the pres-
ence or absence of serum, treated for 20 min with DMSO (control) or
PD98059 (25 
 
m
 
M), and lysed. Lysates were electrophoresed, immunoblot-
ted with anti-p42/44 ERK antibody (Santa Cruz Biotech), and the activa-
tion of MAPK was determined by gel-shift (Cox et al., 1994). Determina-
tion of the mean image density was made using NIH image software.
 
Results
 
R-Ras or TC21 (R-Ras2) Expression Affects the 
Differentiation of Mammary Epithelial Cells in
Three-dimensional Collagen Gel Culture
 
Well differentiated human breast carcinoma T47D cells
maintain the ability to polarize into tubule and ductlike
structures when cultured in three-dimensional collagen
gels (Keely et al., 1995). This differentiation is dependent
on the 
 
a
 
2
 
b
 
1 integrin (Keely et al., 1995; Zutter et al.,
 
1995). One of the characteristics of T47D differentiation
into tubules is the multicellular nature of the structure,
such that individual cell–cell boundaries become more dif-
ficult to distinguish, as can be noted in Fig. 1 A. Stable ex-
pression of activated R-Ras(87L) in T47D cells disrupted
the ability of these cells to differentiate and polarize in col-
lagen gel culture, instead the cells grew as disorganized
clumps and sheets of individual, nonpolarized cells (Fig. 1
B). Similar results were obtained with cells stably express-
ing another activated R-Ras isoform, R-Ras(38V) (not
shown). Thus, activation of R-Ras results in a less differ-
entiated, more transformed phenotype. In contrast, stable
expression of dominant negative R-Ras(43N) enhanced
differentiation; tubule structures developed earlier and
were more extensive (Fig. 1 D). This suggests that endoge-
nous R-Ras may play a negative role in regulating the rate
or extent of normal epithelial differentiation. Like R-Ras,
expression of constitutively active TC21(72L) disrupted
differentiation in collagen gels (Fig. 1 C), whereas expres-
sion of dominant negative TC21(26A) enhanced differen-
tiation in a qualitative manner (Fig. 1 E). This suggested
that TC21, like R-Ras, is a negative regulator of breast cell
differentiation.
 
R-Ras and TC21 Stimulate Migration and Invasion 
Specifically across Collagen
 
Breast carcinoma progression is accompanied by the loss
of polarization and differentiation, and the acquisition
of a migratory invasive phenotype. Migration was deter-
mined using a Boyden chamber haptotactic assay in which
transwells were coated on the underside with collagen.
Expression of activated R-Ras isoforms, R-Ras(87L) or
R-Ras(38V), significantly enhanced cell migration relative
to control cells (Fig. 2 a), indicating that R-Ras activation
promotes a more migratory phenotype. Dominant nega-
tive R-Ras(41A) inhibited migration by 
 
z
 
45–50% (Fig. 2
a), suggesting a contribution of R-Ras to basal migratory
mechanisms. Activated TC21(72L) also enhanced cell mi-
gration, albeit to a somewhat lesser extent than R-Ras
(Fig. 2 a). Expression of activated isoforms of other Ras
family members, N-Ras(12D) and K-Ras(12V), also en-
hanced cell migration across collagen, but to a lesser ex-
tent than R-Ras (Fig. 2 a).
The migration induced by R-Ras(87L) across collagen-
coated filters was dependent on the 
 
a
 
2
 
b
 
1 integrin, since it
could be completely inhibited by anti-
 
a
 
2
 
b
 
1 blocking anti-
bodies (Fig. 2 b). Similarly, TC21(72L)-induced cell migra-
tion was also 
 
a
 
2
 
b
 
1 integrin-dependent (Fig. 2 b). These re-
sults are consistent with the finding that the 
 
a
 
2
 
b
 
1 integrin
is a major collagen receptor in breast epithelial cells that
mediates many of their responses to collagenous matrices
(Keely et al., 1995; Zutter et al., 1995).
To examine whether the effect of R-Ras was specific for
collagen, cell migration across fibronectin was determined.
Surprisingly, expression of R-Ras(87L) or R-Ras(38V) did
not enhance and, in fact, partially inhibited migration
across fibronectin by 
 
z
 
40% (Fig. 2 c). R-Ras(87L) did not
enhance or inhibit migration of cells across laminin (not
shown). Similar results were obtained for TC21(72L),
which also inhibited migration across fibronectin by 25%,
although this difference was not statistically significant 
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(Fig. 2 c). The difference between migration across col-
lagen and fibronectin is not due to dramatically different
levels of migration, since similar numbers of control cells
migrate across each substratum, as shown by a representa-
tive experiment in Table I. In contrast to the results with
R-Ras and TC21, expression of either N-Ras(12D) or
K-Ras(12V) enhanced migration across fibronectin (Fig. 2
c). Thus, R-Ras and TC21 differ from N- and K-Ras in the
specificity of substrata on which they enhance cell migra-
tion.
To metastasize, cells must not only migrate but must
also invade through extracellular matrices. Therefore, we
examined the ability of transfected cells to invade through
 
a 2-mm-thick collagen gel in response to a serum gradient.
Consistent with their more migratory phenotype, cells ex-
pressing activated R-Ras(87L) or R-Ras(38V) were signif-
icantly more invasive through collagen than control cells
(Fig. 3). Similarly, activated TC21(72L), N-Ras(12D), and
K-Ras(12V) induced cell invasion (Fig. 3). Because basal
invasion levels of T47D cells are already so low, we did not
further investigate the effect of dominant negative R-Ras
or TC21 on invasion. Therefore, we find that expression of
activated R-Ras or TC21 converts cells from a polarized,
differentiated phenotype into a migratory and invasive
phenotype.
 
R-Ras Specifically Affects the 
 
a
 
2 Integrin
Cytoplasmic Domain
 
Next, we examined the effect of R-Ras on adhesion of
cells to collagen and fibronectin since R-Ras activation
specifically enhanced cell migration across collagen, but
decreased migration across fibronectin. This was of partic-
ular interest since it has been shown that expression of ac-
tivated R-Ras(38V) increases the adhesion of myeloid
cells to fibronectin and vitronectin through activation of
integrin subunits (Zhang et al., 1996). Similar to these re-
Figure 1. Expression of activated R-Ras or TC21 (R-Ras 2) disrupts the organized polarization of breast epithelia. Cells were cultured
in three-dimensional collagen gels and the formation of polarized tubule structures was assessed by phase-contrast microscopy. Cells
were transfected with: (A) vector only, (B) constitutively active R-Ras(87L), (C) constitutively active TC21(72L), (D) dominant nega-
tive R-Ras(43N), or (E) dominant negative TC21(26A). Constitutively active R-Ras and TC21 disrupt tubule formation, whereas dom-
inant negative R-Ras and TC21 enhance formation in a qualitative manner.
 
Table I. Migration of Cells Expressing Activated R-Ras and 
TC21 on Collagen and Fibronectin
 
Collagen* Fibronectin*
 
Control 93 (
 
6 
 
3) 121 (
 
6 
 
8)
R-Ras(87L) 246 (
 
6 
 
21) 50 (
 
6 
 
4)
TC21(72L) 255 (
 
6 
 
16) 58 (
 
6 
 
5)
 
*Average number of cells per microscopic field for a representative experiment from
Fig. 2. Values represent an average of 6 fields
 
 6
 
 SD. 
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sults, we found that expression of activated R-Ras(87L)
enhanced adhesion to collagen by a modest but consistent
amount (Fig. 4 a), demonstrating an effect of R-Ras acti-
vation on the avidity of cells for collagen. Dominant nega-
tive R-Ras(41A) decreased adhesion to collagen (Fig. 4 a)
by a similar amount, demonstrating a contribution of en-
dogenous R-Ras to cell adhesion. The other dominant
negative isoform of R-Ras, R-Ras(43N), did not affect cell
adhesion (not shown). Expression of TC21 isoforms had
no consistent or significant effect on adhesion of cells to
collagen (not shown). In contrast to the effect on cell ad-
hesion to collagen, expression of R-Ras(87L) or R-Ras-
(41A) did not affect cell adhesion to fibronectin (Fig. 4 b).
This is in contrast to the results of Zhang et al. (1996) who
found increased adhesion of myeloid cells to fibronectin
substrata. This suggests that there are cell-type specific dif-
ferences in the effects of R-Ras on different integrin sub-
units.
To determine whether changes in cell migration and ad-
hesion could be explained by altered expression of endog-
enous integrin subunits, integrin 
 
a
 
 subunit expression was
examined by flow cytometry. Cells expressing activated
R-Ras(87L) or dominant negative R-Ras(41A) or R-Ras-
(43N) showed no change in the expression of integrin sub-
units 
 
a
 
1, a2, a3, a5, or a6 (not shown). Additionally, there
were no changes noted in expression of a4 (not shown), an
integrin subunit not normally expressed in these cells.
Therefore, R-Ras–induced changes in cell migration and
adhesion are not due to changes in integrin subunit ex-
pression.
To examine if an apparent change in integrin avidity was
reflected in a detectable change in integrin conformation,
Figure 2. R-Ras and TC21 stimulate integrin-mediated cell mi-
gration across collagen but not fibronectin. (a) Migration of cells
transfected with Ras family members across collagen I. Expres-
sion of constitutively active R-Ras(87L) and R-Ras(38V) stimu-
late cell migration, whereas dominant negative R-Ras(41A) in-
hibits migration. Expression of constitutively active isoforms of
Ras family members, TC21(72L), N-Ras(12D), and K-Ras(12V)
also stimulate cell migration. Haptotactic cell migration was as-
sayed in the absence of serum across filters coated from the un-
derside with collagen I. Values are relative to migration of cells
expressing vector alone: *P , 0.05, compared with control cells;
(*)P , 0.1. (b) Migration across collagen is mediated by the a2b1
integrin. Cells were preincubated with control IgG or P1E6, an
anti–a2 integrin antibody, and allowed to migrate across filters
coated with collagen I. P1E6 significantly inhibits migration of
control cells as well as cells expressing activated R-Ras(87L) or
TC21(72L). *P , 0.05 for P1E6 compared with control IgG. (c)
Cell migration across fibronectin. Expression of constitutively ac-
tive R-Ras(87L) or (38V) decreases migration, whereas constitu-
tively active TC21(72L) does not. In contrast, expression of
constitutively active N-Ras(12D) or K-Ras(12V) stimulates mi-
gration across fibronectin. *P , 0.05, (*)P , 0.1, compared with
control cells transfected with vector alone.
Figure 3. R-Ras and Ras family members stimulate invasion.
Cells expressing constitutively active R-Ras(87L) or (38V),
TC21(72L), N-Ras(12D), or K-Ras(12V) are significantly more
invasive across collagen gels in response to a serum gradient. Val-
ues are relative to cells transfected with vector alone (control).
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we used a conformationally sensitive anti–b1 integrin anti-
body, 12G10. The 12G10 epitope is known to be expressed
on integrins that are activated by manganese. We found no
increase in 12G10 binding, as determined by flow cytome-
try, in cells expressing R-Ras(87L) compared with control
cells (not shown). This result suggests that changes in ap-
parent integrin avidity because of R-Ras activation either
do not correlate to conformational changes, or that R-Ras
changes integrin conformation in a manner not detected
by this antibody.
The R-Ras–enhanced migration and adhesion of cells to
collagen via a2b1, but not fibronectin via a5b1, suggests
that, in these cells, R-Ras affects specific integrin subunits.
Since the b subunits are identical, we speculated that
R-Ras specifically signals to the a2 cytoplasmic domain.
To test this hypothesis, the effects of R-Ras on a chimeric
integrin containing the a2 cytoplasmic domain were com-
pared with its effects on a similar chimera containing the
a5 cytoplasmic domain. Chimeric integrins with the extra-
cellular domain of the a4 subunit and the cytoplasmic do-
main of either the a2 subunit (X4C2) or the a5 subunit
(X4C5) were transfected into control and R-Ras(87L)–
expressing cells. Some cells were instead transfected with
the complete a4 subunit (X4C4). We selected a4 integrin
chimeras since T47D cells normally do not express the a4
subunit (Fig. 5 A, mock profile) which allowed us to moni-
tor the expression of the chimeras in our control and
R-Ras–transfected cells. Each of the a4 chimeras was ex-
pressed at similar levels on the surface of control and
R-Ras–expressing cells (Fig. 5, A–F). Since individual in-
tegrin a subunits are not expressed on the cell surface, this
indicates that a4b1 heterodimers were formed. Impor-
tantly, expression of a4 chimeras did not affect the expres-
sion of endogenous a2 (Fig. 5, G and H) or a5 subunits
(not shown).
The ligand for the a4b1 integrin is the CS-1 sequence
found in the COOH-terminal 40-kD heparin-binding frag-
ment of fibronectin (McCarthy et al., 1986; Humphries et
al., 1987). This 40-kD fragment does not contain the RGD
sequence that is the ligand for the a5b1 integrin in fi-
bronectin. Therefore, to specifically assess the effects of
R-Ras expression on the X4 chimeras, cell migration
across membranes coated with either the CS-1 peptide or
the 40-kD fragment was determined, since untransfected
T47D cells do not migrate across these substrata (not
shown). We found that expression of the X4 chimeras in
T47D cells conferred the ability to migrate on the 40-kD
fragment and the CS-1 peptide (Fig. 6 a). Interestingly,
R-Ras(87L) enhanced migration of cells expressing X4C2
and decreased migration of cells expressing X4C5 (Fig. 6
a). This is consistent with our finding that R-Ras enhances
migration across collagen and decreases migration across
fibronectin (Fig. 2). R-Ras(87L) also enhanced migration
of X4C4-expressing cells, suggesting that R-Ras not only
signals to the a2, but also the a4 cytoplasmic domains in
breast epithelial cells (Fig. 6 a). Cells expressing an a4 chi-
mera containing no a cytoplasmic domain, X4C0, were un-
able to migrate across the 40-kD and CS-1 substrata (not
shown), indicating the importance of an intact a cytoplas-
mic domain for cell migration. These results suggest that
R-Ras activation enhances a2b1 integrin function and di-
minishes a5b1 integrin function, at least with regard to cell
migration.
We also determined whether cells expressing a4 chime-
ras had altered migration across collagen. Since the a4 chi-
meras do not bind collagen, any effect will be due to pleio-
tropic effects on endogenous integrin subunits. Expression
of X4C2, but not X4C4 or X4C0, blocked the increase in
migration of cells across collagen that is induced by acti-
vated R-Ras(87L) (Fig. 6 b), suggesting that there is some
form of competition between the X4C2 subunit and the
endogenous a2 subunit. Thus, the effects of R-Ras on en-
dogenous a2 subunits can be antagonized specifically by
de novo expression of a2 cytoplasmic domains. Such dom-
inant negative effects of integrin cytoplasmic domains
have been noted previously with expression of exogenous
b cytoplasmic domains (Y.P. Chen et al., 1994; LaFlamme et
al., 1994; Lukashev et al., 1994). However, this is the first
Figure 4. Activated R-Ras enhances adhesion to collagen but not
fibronectin. (A) Cells expressing activated R-Ras(87L) (trian-
gles) are more adherent to collagen I than control cells express-
ing vector alone (open squares). In contrast, cells expressing
dominant negative R-Ras(41A) (filled squares) are less adherent
to collagen I. (b) Cells expressing activated or dominant negative
R-Ras are no different from control cells in their adhesion to fi-
bronectin. Values in a and b are an average of two separate ex-
periments, each of triplet determinations, 6 SD.Keely et al. R-Ras Signals Specific Integrin a Subunits 1083
demonstration of transdominant inhibition by a specific a
integrin subunit. This suggests that there may be competi-
tion for a limited supply of a cytoplasmic domain binding
factors. Conversely, X4C5 expression slightly enhanced the
R-Ras(87L)–induced migration across collagen (Fig. 6 b),
although this enhancement is not statistically significant when
compared to the results obtained with cells expressing
X4C4 or X4C0. These results provide additional evidence
that R-Ras signaling involves specific integrin subunits.
PI3K and PKC Contribute to R-Ras– and
TC21-induced Cell Migration
We previously found that migration induced by the small
GTPases, Rac and Cdc42, was dependent on PI3K (Keely
et al., 1997). Like Rac and Cdc42, R-Ras also has been
shown to activate PI3K (Marte et al., 1996). Therefore, we
determined whether pharmacological inhibitors of PI3K,
Wortmannin, and LY294002, could inhibit the migration
induced by R-Ras. Wortmannin (30 nM) and LY294002
(25 mM) significantly inhibited the migration induced by
activated R-Ras(87L) or R-Ras(38V) (Fig. 7 a). However,
unlike the total inhibition previously noted with Rac and
Cdc42-expressing cells (Keely et al., 1997), the effect of
PI3K inhibition on R-Ras–induced migration was only
partial; migration was inhibited only by z50%. Wortman-
nin and LY294002 also only partially inhibited the migra-
tion induced by activated TC21(72L) (Fig. 7 a). Thus,
PI3K activity contributes to R-Ras–induced cell migration,
but other signaling pathways are probably also involved.
PKC has been implicated in the migration of some cell
types (Vuori and Ruoslahti, 1993; Derman et al., 1997;
Batlle et al., 1998). Pretreatment of cells with 1 mM bisin-
dolylmalemide, an inhibitor of most isoforms of PKC,
significantly inhibited the migration of R-Ras(87L) or
R-Ras(38V)–expressing cells (Fig. 7 b). Once again, inhib-
iting PKC produced only partial inhibition of R-Ras–
induced cell migration. Bisindolylmalemide also partially
inhibited the migration of cells expressing TC21(72L) and
K-Ras(12V), albeit to an even lesser extent than the effect
on R-Ras cells (not shown). The concentration of bisin-
dolylmalemide used was adequate, since pretreatment of
cells with this concentration inhibited PKC activity to
background levels in an in vitro PKC kinase assay (data
not shown). Since certain isoforms of PKC (d, e, and h)
can be activated downstream of PI3K (Toker et al., 1994;
Derman et al., 1997), we wished to determine if PKC and
PI3K might be part of the same signaling pathway leading
to cell migration, or separate pathways that both contrib-
ute to migration. Treatment of cells with Wortmannin and
bisindolylmalemide had an additive effect and completely
inhibited the increased migration induced by R-Ras ex-
Figure 5. Flow cytometry of cells expressing a4 integrin chimeras. (A–F) De novo expression of a4 integrin on the surface of control or
R-Ras(87L)–expressing cells double-transfected with a4 chimeras. Chimeras consist of the extracellular domain of the a4 subunit and
the cytoplasmic domain of a2 (X4C2), a4 (X4C4), or a5 (X4C5). All cell lines expressed similar levels of the X4 chimeras as determined
by surface a4 integrin expression. (A) Control cells transfected with X4C2 express a4 on their surface (shaded histogram). In contrast,
mock-transfected cells, like untransfected cells, do not express a4 on their surface (open histogram). (B) R-Ras(87L) cells transfected
with X4C2 express similar levels of a4 as control X4C2 cells in A. (C) Control cells transfected with X4C4. (D) R-Ras(87L) cells trans-
fected with X4C4. (E) Control cells transfected with X4C5. (F) R-Ras(87L) cells transfected with X4C5. (G and H) Cell surface expres-
sion of a2b1 integrin does not change in cells transfected with X4C2. (G) Control cells transfected with X4C2 (shaded histogram) have
similar levels of a2 expression on their surface as mock-transfected cells (open histogram). (H) R-Ras(87L) cells transfected with X4C2
also have similar a2 expression levels.The Journal of Cell Biology, Volume 145, 1999 1084
pression (Fig. 7 b), suggesting that PI3K and PKC each
contribute to R-Ras–induced cell migration through sepa-
rate pathways.
Other pharmacological inhibitors of signaling pathways
potentially downstream of R-Ras were also tested. The
MEK inhibitor, PD98059 (Dudley et al., 1995), had no ef-
fect on migration induced by activated R-Ras or TC21
Figure 6. R-Ras specifically enhances migration through effects
on the a2 integrin cytoplasmic domain. (a) Migration of cells
across ligands specific for the a4b1 integrin: the 40-kD frag-
ment of fibronectin or the CS-1 peptide. Cell lines expressing
control vector or activated R-Ras(87L) were double-transfected
with a4 chimeras that consist of the extracellular domain of the
a4 subunit and the cytoplasmic domain of a2 (X4C2), a4 (X4C4),
or a5 (X4C5). R-Ras(87L) enhances migration only for cells ex-
pressing the X4C2 or X4C4 chimeras, but not cells expressing the
X4C5 chimera. Values are normalized for each chimera set and
substratum to control values. *P , 0.05 compared with control
cells for that chimera. (b) Migration of cells expressing X4 chime-
ras across collagen I, which is not a ligand for the a4 extracellular
domain. Expression of X4C2 inhibits the increase in cell migra-
tion across collagen induced by R-Ras(87L) expression. In con-
trast, expression of X4C4, X4C5, or X4C0 (a4 extracellular
domain with no cytoplasmic domain) did not inhibit R-Ras-
(87L)–induced cell migration across collagen (i.e., R-Ras still in-
duces a statistically significant increase in the migration of these
cells). Values are normalized for each chimera set. *P , 0.05
compared with control values (solid bars) for that chimera. Ex-
pression of X4C5 actually increases the effect of R-Ras, but this
is not statistically significant, when compared with X4C4, or
X4C0-expressing cells.
Figure 7. PI3K and PKC contribute to R-Ras induced cell migra-
tion. (a) Pretreatment with PI3K inhibitors Wortmannin (Wtm,
30 nM) or LY294002 (LY, 25 mM) partially inhibits the mi-
gration of cells expressing activated R-Ras(87L) or (38V), or
TC21(72L) across collagen. *P , 0.05 compared with DMSO-
treated samples for each cell line shown. (b) Pretreatment of cells
with the PI3K inhibitor, Wortmannin (Wtm, 30 nM), or the PKC
inhibitor, bisindolylmalemide (Bis, 1 mM), or both. Wortmannin
and bisindolylmalemide alone each partially inhibits R-Ras–
induced migration of cells across collagen. Together, Wortman-
nin and bisindolylmalemide have an additive effect and com-
pletely inhibit R-Ras–induced migration. *P , 0.05 compared
with DMSO-treated samples for each cell line. (c) Pretreatment
of cells with the MEK inhibitor, PD98059 (PD98, 25 mM) has no
effect on the migration across collagen of cells expressing acti-
vated R-Ras(87L) or (38V) or TC21(72L). In contrast, PD98059
completely inhibits migration induced by activated K-Ras(12V).
*P , 0.05 compared with DMSO-treated samples for each cell
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(Fig. 7 c), despite inhibiting MAPK activation 50–60% in
cells expressing R-Ras(38V), R-Ras(87L), or TC21(72L)
(data not shown). In sharp contrast, PD98059 significantly
inhibited K-Ras–induced cell migration (Fig. 7 c), demon-
strating important differences in the mechanism by which
R-Ras and K-Ras induce migration. Rapamycin, an inhibi-
tor of p70 S6 kinase, also did not inhibit cell migration (not
shown), which is consistent with previous results with Rac
and Cdc42 (Keely et al., 1997).
Discussion
In this study, we show that activated R-Ras disrupts mam-
mary epithelial polarization in three-dimensional collagen
gels and induces migration and invasion across collage-
nous matrices. These results implicate a role for R-Ras in
the transformation of mammary epithelial cells, a role that
has not been described previously. We find similar results
for a molecule closely related to R-Ras, TC21, which ex-
tends previous results by Clark et al. (1996) demonstrating
that TC21 can alter breast epithelial morphology. We also
find that R-Ras enhances cell adhesion to collagen, which
is consistent with its previously described role in promot-
ing increased integrin avidity (Zhang et al., 1996). Impor-
tantly, R-Ras enhances cell migration and adhesion specif-
ically on collagen, but not fibronectin. This substratum
specificity reflects a difference in the effect of R-Ras on
the a2 versus the a5 integrin cytoplasmic domains. Such
specificity has not been described previously for the ef-
fects of R-Ras on integrin subunits, and could have impor-
tant implications for inside-out integrin signaling events
that lead to migration and invasion on collagenous ma-
trices. Finally, migration induced by R-Ras is partially
blocked by inhibitors of PI3K and PKC, but not by a MEK
inhibitor, suggesting that unique combinations of signaling
pathways are activated by R-Ras compared with other
members of the Ras superfamily.
Currently, it is not understood how different integrin
subunits specifically link to different inside-out or outside-
in signaling pathways. Here, we demonstrate that R-Ras
can stimulate cellular migration that is dependent on the
a2b1 or a4b1 integrin, but not the a5b1 integrin. In fact,
R-Ras activation seems to have a slight inhibitory effect
on a5b1-mediated cell migration. The effect of R-Ras is
specifically on the a cytoplasmic domain since only this
domain differs between the X4C2 and X4C5 chimeras.
Our results are consistent with other observations that a
subunits appear to regulate the specificity and appropri-
ateness of integrin response. For example, swapping inte-
grin a cytoplasmic domains on the a2 integrin changes the
response of cells to collagen (Chan et al., 1992), whereas
deletion of the a2 cytoplasmic domain causes unregulated
recruitment of integrins into focal complexes, even when
the cells are attached to fibronectin (Kawaguchi et al.,
1994). Here we are able to link a specific signaling path-
way involving R-Ras to the a2b1 integrin, which may help
explain these previous observations regarding specific a2
subunit effects. Activation of MAPK by integrins also de-
pends on specific integrin subunits (Wary et al., 1996; Wei
et al., 1998). Specifically, a5b1 integrin, but not a2b1 inte-
grin, associates with Shc and activates the MAPK pathway
in osteosarcoma cells (Wary et al., 1996). The failure of
a2b1 to couple to the MAPK pathway may partially ex-
plain why R-Ras–induced migration through a2b1 was un-
affected by MEK inhibition. Our results imply that cell mi-
gration will differ on different matrices, depending in part
on the signaling pathway that has been activated.
Our finding that R-Ras enhances cell adhesion to col-
lagen suggests that R-Ras enhances a2b1 integrin avidity
for its ligand. An increase in integrin avidity is consistent
with the findings of Zhang et al. (1996). However, we find
that R-Ras enhances a2b1- but not a5b1-mediated adhe-
sion, whereas Zhang et al. noted that R-Ras enhances ad-
hesion to fibronectin through a4b1, a5b1, and avb3 inte-
grins (Zhang et al., 1996). This difference could relate to
the difference between the myeloid cells used in those
studies and the epithelial cells used here. The R-Ras–
induced increase in avidity determined by cell adhesion
could not be correlated to conformational changes of the
integrin as detected by the 12G10 anti-b1 antibody. Other
investigators have also noted a lack of correlation between
ligand binding capability and b1 conformation as detected
by various conformationally sensitive antibodies (Bazzoni
and Hemler, 1998; Crommie and Hemler, 1998). Our re-
sult could mean that R-Ras alters integrin conformation in
a manner not detected by this antibody. Alternatively,
changes in integrin avidity after R-Ras activation may not
be due to obvious conformational changes but to alter-
ations in integrin clustering, adhesion strengthening, or cy-
toskeletal attachments.
It is not clear at this point how R-Ras stimulation differ-
entiates between the a2 and a5 integrin subunits. An at-
tractive model invokes proteins or factors that bind specif-
ically to either the a2 or a5 integrin subunits. Stimulation
of R-Ras may alter the binding properties of such mol-
ecules, perhaps through phosphorylation/dephosphoryla-
tion events or membrane targeting. These molecules could
bind to specific integrin subunits and activate their ligand
binding properties, or could alter integrin association with
the cytoskeleton. Alternatively, these factors could be in-
hibitory, such that R-Ras activation releases the integrin
subunit from inhibition by these factors. Our finding that
the X4C2 chimera blocks the R-Ras–induced migration of
cells on collagen, which is not a ligand for X4C2, suggests
that X4C2 acts as a dominant negative molecule in this
case, presumably through competition for these putative
integrin binding molecules. Such transdominant inhibition
has been suggested to explain how one integrin b subunit
can inhibit the function of another (Balzac et al., 1994;
Diaz-Gonzalez et al., 1996; Fenczik et al., 1997) or how
chimeras expressing the cytoplasmic tail of the b subunit
suppress integrin function (Y.P. Chen et al., 1994; LaFlamme
et al., 1994; Lukashev et al., 1994). Interestingly, trans-
dominant b1 integrin suppression can be overcome by ex-
pression of CD98 (Fenczik et al., 1997), lending support to
the notion that accessory binding molecules regulate inte-
grin function. To our knowledge, ours is the first demon-
stration of transdominant inhibition on a integrin subunits
and implies that factors bind not only to the b, but also the
a cytoplasmic domains. Future studies should identify fac-
tors specific for the a2 cytoplasmic domain that may play a
role in R-Ras–enhanced integrin adhesion and migration.
The fact that R-Ras specifically enhances a2b1 integrin–
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ing in light of previous work specifically implicating the
a2b1 integrin in these events in mammary epithelial cells
(Keely et al., 1995; Zutter et al., 1995). Thus affecting
a2b1 function, either through changes in expression levels
or by inside-out signaling events, has important conse-
quences for the phenotype of these cells. It is intriguing
that apparent increased function of the a2b1 integrin by
R-Ras results in the same outcome of increased migration
and decreased cell polarization that is noted when a2b1
levels are decreased (Keely et al., 1995). This could indi-
cate that R-Ras activation fundamentally changes the sig-
naling pathways used by the a2b1 integrin, disrupting the
normal signaling events that cause the cell to differentiate
and polarize in response to the extracellular matrix.
These same normal signaling events could be disrupted or
diminished when a2b1 levels are decreased, as is noted in
breast carcinomas (Zutter et al., 1990). It will be interest-
ing in future studies to determine exactly how cross-talk
between the a2b1 integrin and R-Ras affects cellular dif-
ferentiation, migration, and invasion.
We find a new role for endogenous R-Ras and TC21 in
the differentiation and migration of breast epithelial cells.
Dominant negative R-Ras inhibits basal cell migration,
suggesting that endogenous R-Ras plays a role in the mi-
gration of breast epithelial cells. Additionally, we find that
inhibitors of PI3K and PKC partially inhibit basal migra-
tion, consistent with our model that these molecules are
part of the mechanism by which R-Ras contributes to cell
migration, whether basal or induced. This further suggests
that the signaling pathways under investigation here are
likely relevant to understanding the migration of sponta-
neously occurring breast carcinomas. Dominant negative
isoforms of R-Ras or TC21 also enhance tubulogenesis in
three-dimensional collagen culture, indicating that antago-
nizing activated R-Ras or TC21 promotes differentiation.
This suggests that activated R-Ras and TC21 are negative
regulators of breast cell differentiation, consistent with the
finding that expression of activated R-Ras or TC21 iso-
forms disrupt tubulogenesis. These results could suggest
that activation of R-Ras and TC21 turns on signaling path-
ways that are incompatible with the decision of a cell to
slow proliferation and differentiate. Thus, inappropriate
activation of R-Ras or TC21 could result in a cell with a
more migratory and less differentiated phenotype, which
is consistent with a role in transformation.
Our results add to the growing body of evidence point-
ing to an important role for PI3K in cellular migration
events (Kundra et al., 1994; Keely et al., 1997; Shaw et al.,
1997; Khwaja et al., 1998). The effect of R-Ras on PI3K
possibly is direct since it has been shown that R-Ras binds
to PI3K in vitro and activates PI3K in Cos-7 cells (Marte
et al., 1996). Since R-Ras has direct effects on integrin
avidity, it is interesting that a role for PI3K in affecting in-
tegrin activation has been shown in lymphocytes (Shimizu
et al., 1995) and platelets (Kovacsovics et al., 1995). Other
Ras superfamily members, including H-Ras, Cdc42, and
Rac, also bind and activate PI3K (Rodriguez-Viciana et
al., 1994; Zheng et al., 1994; Tolias et al., 1995), which in
the case of H-Ras plays an important role in cellular trans-
formation (Hu et al., 1995; Rodriguez-Viciana et al., 1997).
We previously found a role for PI3K in migration induced
by Rac and Cdc42 (Keely et al., 1997) as well as by N- and
K-Ras (Keely, P., unpublished observation). Consistent
with these observations, expression of activated PI3K pro-
motes migration and invasion (Keely et al., 1997; Shaw et
al., 1997).
Although R-Ras is similar to Ras, Rac, and Cdc42 in its
use of a PI3K signaling pathway, it differs in its use of
other signaling pathways. Migration induced by R-Ras
or TC21 was only partially blocked by PI3K inhibitors;
this effect was much less dramatic than for migration in-
duced by Rac and Cdc42, which could be completely
blocked by the same concentrations of these PI3K in-
hibitors (Keely et al., 1997). This suggests that PI3K-inde-
pendent signaling pathways also contribute to R-Ras–
stimulated migration in these cells. Although MEK and
MAPK activation have been implicated in cell migration
in various cells (Klemke et al., 1997), we found that MEK
inhibition did not affect migration induced by R-Ras or
TC21. In contrast, MEK inhibition completely abolished
migration induced by K- and N-Ras. These results are con-
sistent with observations that R-Ras activates PI3K but
not Raf (Herrmann et al., 1996; Marte et al., 1996; Huff et
al., 1997), unlike H-, N-, and K-Ras, which activate both
PI3K and the Raf-MAPK pathway (Vojtek et al., 1993;
Rodriguez-Viciana et al., 1997). Since a recent report sug-
gests that the Raf-MAPK pathway might be involved in
transformation by TC21 (Rosario et al., 1999), our results
suggest that the mechanisms by which TC21 induces mi-
gration and transformation differ. Moreover, it appears
that different small GTPases stimulate cell migration by
activating different combinations of downstream signaling
pathways. The use of different signaling pathways may ex-
plain why R-Ras differs from N- and K-Ras in stimulating
migration across fibronectin.
We find a role for PKC, in addition to PI3K, in migra-
tion induced by R-Ras. Although certain isoforms of PKC
(d, e, and h) can be activated downstream of PI3K and
contribute to cell migration (Toker et al., 1994; Derman
et al., 1997), the additive effect of PI3K and PKC inhibi-
tors in our assays suggests that PKC is on a separate path-
way from PI3K in these cells. Whether PKC is down-
stream of R-Ras, or part of an independent obligate
pathway remains to be determined. To this end, we did not
observe an increase in in vitro PKC activity in cells ex-
pressing R-Ras in preliminary experiments (our unpub-
lished observation), although translocation of PKC to the
membrane and subsequent activation in R-Ras–expressing
cells cannot be ruled out. Dominant negative R-Ras was
unable to block cell migration induced by PMA (our un-
published results), suggesting PKC is not upstream of
R-Ras in our system. In addition to R-Ras, we find a role
for PKC in migration induced by K-Ras. Others also have
noted synergy between PKC and small GTPases. The Rac
exchange factor, Tiam-1, can be activated by PKC (Flem-
ing et al., 1997), which would place PKC upstream of Rac
activation. Similarly, PKC is upstream of Ras activation in
platelets (Shock et al., 1997). Additionally, PKC activation
synergizes with Rho to induce focal adhesion kinase phos-
phorylation, cell spreading, and actin assembly (Lewis et
al., 1996; Defilippi et al., 1997). Interestingly, activation of
the a2b1 integrin in monocytes by ligand binding to a5b1
requires PKC (Pacifici et al., 1994), which would be consis-
tent with a model in which PKC is part of the pathway byKeely et al. R-Ras Signals Specific Integrin a Subunits 1087
which R-Ras enhances avidity of the a2b1 integrin. More-
over, PKC activation is involved in activation of the
aIIbb3 integrin by a number of agonists in platelets
(Karniguian et al., 1990). Our results are also consistent
with other observations that PKC activity contributes to
cell migration (Vuori and Ruoslahti, 1993; Derman et al.,
1997; Batlle et al., 1998).
In summary, we find that activation of R-Ras stimulates
unique combinations of downstream signaling pathways
compared with other GTPases of the Ras superfamily.
These unique signaling combinations lead to specific ef-
fects on certain integrin a subunits to alter cellular re-
sponses to collagen such as polarization, migration, and
invasion. Such specificity will decide how a cell might re-
spond to different extracellular environments, depending
on which Ras family member is activated, and could ulti-
mately determine if a given carcinoma is metastatic or not.
These differences have important implications for target-
ing signaling pathways in antimetastatic therapies since af-
fecting certain signaling pathways may not have the de-
sired effects on all neoplastic cells.
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